Analysis of correlation between dynamic contrast-enhanced ultrasound and angiogenesis activity of renal cell carcinoma

Abstract

Purpose

To investigate the potential correlation of dynamic contrast-enhanced ultrasound (DCE-US) with angiogenesis activity of renal cell carcinoma (RCC).

Materials and Methods

Patients with surgery resection and histopathologically proven RCC lesions were included. B-mode ultrasound (BMUS) and contrast-enhanced ultrasound (CEUS) were performed one week before surgery. SonoVue was injected as the contrast agent. VueBox (Bracco, Italy) was used for the quantitative analysis. According to the histopathological and immunohistochemical results, patients were classified into two groups: active angiogenesis and inactive angiogenesis. Time intensity curves (TICs) and quantitative parameters were compared between two groups.

Results

From July 2023 to November 2023, a total of 50 patients (13 females and 37 males, mean age 61.1±11.1 years) were included. The mean size of the lesions was 39.4±2.7 mm. Patients were classified into the active angiogenesis group (n=30) and the inactive angiogenesis group (n=20). On BMUS, 68.0% (34/50) of RCCs were visualized as hypoechoic lesions with ill-defined borders and irregular shapes (P>0.05). During cortical phase of CEUS, 72.6% (23/30) of RCCs with active angiogenesis were visualized with hyperenhancement (P=0.027). Only 30.0% (9/30) of RCCs with active angiogenesis showed hypo-enhancement in the parenchymal phase (P>0.05). Compared to the inactive angiogenesis group, TICs of the active angiogenesis group revealed faster and greater enhancement in the cortical phase, slower decline during the parenchymal phase, and an increased area under the curve. Among quantitative parameters, the active angiogenesis group showed the higher ratio of wash-in rate and wash-in perfusion index (P<0.05).

Conclusion

DCE-US analysis has potential value in predicting angiogenesis activity in RCC lesions.

Keywords

tumor - urinary - surgery - ultrasound

Publikationsverlauf

Eingereicht: 04. Juli 2024

Angenommen nach Revision: 05. Januar 2025

Artikel online veröffentlicht:
15. September 2025

• References

• 1 Rahib L, Wehner MR, Matrisian LM. et al Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open 2021; 4: e214708
• 2 Motzer RJ, Jonasch E, Agarwal N. et al Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017; 15: 804-834
• 3 Jilaveanu LB, Puligandla M, Weiss SA. et al Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805. Clin Cancer Res 2018; 24: 217-223
• 4 del Puerto-Nevado L, Rojo F, Zazo S. et al Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy. Br J Cancer 2014; 110: 2700-2707
• 5 Sharma SG, Aggarwal N, Gupta SD. et al Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol 2011; 43: 125-129
• 6 Motzer RJ, Jonasch E, Boyle S. et al NCCN Guidelines Insights: Kidney Cancer, Version 1.2021. J Natl Compr Canc Netw 2020; 18: 1160-1170
• 7 Sidhu PS, Cantisani V, Dietrich CF. et al The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med 2018; 39: e2-e44
• 8 Zhao P, Zhu J, Wang L. et al Comparative diagnostic performance of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for differentiating clear cell and non-clear cell renal cell carcinoma. Eur Radiol 2023; 33: 3766-3774
• 9 He M, Gao Q, Xiang J. et al Diagnostic Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound for Pathological Subtypes of Small Solid Renal Masses. J Ultrasound Med 2023; 42: 1663-1673
• 10 Wiesinger I, Jung F, Jung EM. Contrast-enhanced ultrasound (CEUS) and perfusion imaging using VueBox(R). Clin Hemorheol Microcirc 2021; 78: 29-40
• 11 Liu H, Cao H, Chen L. et al The quantitative evaluation of contrast-enhanced ultrasound in the differentiation of small renal cell carcinoma subtypes and angiomyolipoma. Quant Imaging Med Surg 2022; 12: 106-118
• 12 Atri M, Hudson JM, Sinaei M. et al Impact of Acquisition Method and Region of Interest Placement on Inter-observer Agreement and Measurement of Tumor Response to Targeted Therapy Using Dynamic Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2016; 42: 763-768
• 13 Bex A, Fournier L, Lassau N. et al Assessing the response to targeted therapies in renal cell carcinoma: technical insights and practical considerations. Eur Urol 2014; 65: 766-777
• 14 Dietrich CF, Correas JM, Cui XW. et al. EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion. Ultraschall Med 2023;
• 15 Drljevic-Nielsen A, Rasmussen F, Nielsen PS. et al Prognostic value of DCE-CT-derived blood volume and flow compared to core biopsy microvessel density in patients with metastatic renal cell carcinoma. Eur Radiol Exp 2021; 5: 32
• 16 Drljevic-Nielsen A, Mains JR, Thorup K. et al Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma. Eur Radiol 2022; 32: 7323-7334
• 17 Coy H, Young JR, Pantuck AJ. et al Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma. Abdom Radiol (NY) 2020; 45: 3184-3192
• 18 Yin Q, Hung SC, Wang L. et al Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study. Sci Rep 2017; 7: 43356
• 19 Zhang X, Zhang G, Xu L. et al Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT. Acad Radiol 2023; 30: 2321-2328
• 20 Dong Y, Qiu Y, Yang D. et al Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Clin Hemorheol Microcirc 2021; 77: 461-469
• 21 Zhang B, Wu Q, Qiu X. et al Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma. BMC Cancer 2021; 21: 874
• 22 Denize T, Farah S, Cimadamore A. et al Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial. Clin Cancer Res 2022; 28: 748-755
• 23 Iakovlev VV, Gabril M, Dubinski W. et al Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Lab Invest 2012; 92: 46-56
• 24 Zhang B, Li J, Wu Z. et al Contrast-Enhanced Ultrasound Characteristics of Renal Pelvis Urothelial Carcinoma and Its Relationship with Microvessel Density. Ultrasound Med Biol 2021; 47: 236-243
• 25 Dong Y, Koch JBH, Lowe AL. et al VueBox(R) for quantitative analysis of contrast-enhanced ultrasound in liver tumors1. Clin Hemorheol Microcirc 2022; 80: 473-486
• 26 Selby NM, Williams JP, Phillips BE. Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases. Curr Opin Nephrol Hypertens 2021; 30: 138-143
• 27 Cao H, Fang L, Chen L. et al The Value of Contrast-Enhanced Ultrasound in Diagnosing Small Renal Cell Carcinoma Subtypes and Angiomyolipoma. J Ultrasound Med 2022; 41: 1415-1423
• 28 Huang X, Wang N, Liu L. et al Pre-operative Prediction of Invasiveness in Renal Cell Carcinoma: The Role of Conventional Ultrasound and Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2023; 49: 2169-2176
• 29 Sun D, Wei C, Li Y. et al Contrast-Enhanced Ultrasonography with Quantitative Analysis allows Differentiation of Renal Tumor Histotypes. Sci Rep 2016; 6: 35081
• 30 Li CX, Lu Q, Huang BJ. et al Quantitative evaluation of contrast-enhanced ultrasound for differentiation of renal cell carcinoma subtypes and angiomyolipoma. Eur J Radiol 2016; 85: 795-802
• 31 Dietrich CF, Correas JM, Cui XW. et al EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion. Ultraschall Med 2024; 45: 36-46